PH20 polypeptide variants, formulations and uses thereof
US12104184B2 · kind B2 · utility
0Cited by
88References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2022 |
| Grant date | Oct 1, 2024 |
| Priority date | — |
| Expiry date | Jan 2, 2043 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.